Compare NVRI & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVRI | NPCE |
|---|---|---|
| Founded | 1853 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical Specialities |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.1M | 490.2M |
| IPO Year | 2026 | 2021 |
| Metric | NVRI | NPCE |
|---|---|---|
| Price | $20.65 | $14.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $18.33 |
| AVG Volume (30 Days) | ★ 255.4K | 109.0K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $99,986,000.00 |
| Revenue This Year | $3.87 | $0.90 |
| Revenue Next Year | $3.70 | $24.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $11.15 | $9.22 |
| 52 Week High | $24.20 | $19.60 |
| Indicator | NVRI | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 39.60 | 49.93 |
| Support Level | $20.27 | $13.76 |
| Resistance Level | $23.68 | $14.72 |
| Average True Range (ATR) | 0.77 | 0.51 |
| MACD | -0.24 | -0.00 |
| Stochastic Oscillator | 6.11 | 38.22 |
Enviri Corp provides environmental and operational solutions to the metal and rail industries. It is based in Philadelphia, Pennsylvania, and operates in more than 30 countries. The company leverages industrial expertise to help customers improve operational performance, recover value from byproducts, enhance sustainability, and maintain critical infrastructure. Its divisions are Harsco Environmental and Harsco Rail, which combine deep operational capabilities with technologies and world-wide scale to deliver long-term value for customers, communities, and shareholders.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.